Cyclosporine A LNP Formulation
Inflammatory/Autoimmune conditions (Ophthalmology, Dermatology, etc.)
Pre-clinicalActive
Key Facts
Indication
Inflammatory/Autoimmune conditions (Ophthalmology, Dermatology, etc.)
Phase
Pre-clinical
Status
Active
Company
About Eyesiu Medicines
Eyesiu Medicines is a private, pre-clinical stage biotechnology company leveraging a patented lipid nanoparticle platform for drug delivery. Its core technology enables the formulation of lipophilic compounds like PEA and cyclosporine A into stable, solvent-free nanoparticles for rapid sublingual, topical, or systemic delivery. The company has launched its first nutraceutical product (PEArlboost spray and shampoo) to generate early revenue while advancing a therapeutic pipeline targeting neurology, ophthalmology, dermatology, and pulmonology. Eyesiu is currently raising public funding through its Eyevestor platform to finance further development.
View full company profile